Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
12%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
IBRN
74
HOLDINGS
10%
ALSO IN PSIL
PSIL
30
HOLDINGS
42%
ALSO IN IBRN
SECTOR DRIFT (IBRN minus PSIL)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBRN |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
| ALKERMES PLC | 4.3% | 4.7% | 4.3% | |
| NEUROCRINE BIOSCIENCES INC | 3.7% | 4.5% | 3.7% | |
| SUPERNUS PHARMACEUTICALS INC | 3.0% | 7.7% | 3.0% | |
| BRIGHT MINDS BIO | 0.9% | 4.2% | 0.9% | |
| RELMADA THERAPEUTICS INC | 0.5% | 8.4% | 0.5% | |
IBRN Overweight Relative to PSIL
| ARGENX SE ADR | 4.1% | |
| AXSOME THERAPEUTICS, INC. | 4.1% | |
| SCHOLAR ROCK HOLDING CORP. | 4.1% | |
| ARROWHEAD PHARMACEUTICALS, INC. | 4.0% | |
| PTC THERAPEUTICS INC | 4.0% | |
| ACADIA PHARMACEUTICALS INC | 3.6% | |
| DIANTHUS THERAPEUTICS INC | 3.6% | |
| BIOGEN IDEC INC | 3.5% | |
| CATALYST PHARMACEUTICAL PART | 3.0% | |
| DENALI THERAPEUTICS INC. | 3.0% |
IBRN Underweight Relative to PSIL
| ATAI LIFE SCIENCES N.V. | -12.2% | |
| RELMADA THERAPEUTICS INC | -7.9% | |
| SUPERNUS PHARMACEUTICALS INC | -4.6% | |
| ALTO NEUROSCIENCE INC | -4.4% | |
| ABBVIE INC | -3.6% | |
| JOHNSON & JOHNSON | -3.4% | |
| BRIGHT MINDS BIO | -3.3% | |
| NEURONETICS, INC. | -2.0% | |
| INCANNEX HEALTHCARE INC. | -1.3% | |
| NUMINUS WELLNESS INC | -1.0% |